Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25176944 | 0.93 | TSHR (0.59) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL30909310 | 0.93 | TSHR (0.59) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL30909315 | 0.93 | TSHR (0.59) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL25167784 | 0.93 | TSHR (0.59) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL8962338 | 0.92 | TSHR (0.81) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| Ammonia Solution, Strong SCHEMBL28386014 | 0.90 | TSHR (0.62) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL1885863 | 0.90 | TSHR (0.67) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL872327 | 0.90 | TSHR (0.67) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL8916348 | 0.89 | TSHR (0.88) | TSHRCYP3A4 | |
| SCHEMBL10416347 | 0.89 | TSHR (0.55) | TSHRCYP3A4ALDH1A1TP53TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015372-A1 | Organophosphorous Compounds and Uses Thereof | JAL THERAPEUTICS LLC (US) | 2026-01-15 | — | — | US | claimed |
| WO-2024020507-A2 | ORGANOPHOSPHOROUS COMPOUNDS AND USES THEREOF | JAL THERAPEUTICS, LLC (US) | 2024-01-25 | — | — | WO | claimed |
| US-8475934-B2 | Flame-retardant timber materials | LANXESS DEUTSCHLAND GMBH (DE) | 2013-07-02 | — | — | US | claimed |
| US-20120058358-A1 | Flame-retardant timber materials | LANXESS DEUTSCHLAND GMBH (DE) | 2012-03-08 | — | — | US | claimed |
| EP-1746129-B1 | Halogenfree, flameretardant polyurethane foams | LANXESS DEUTSCHLAND GMBH (DE) | 2009-01-14 | — | — | EP | claimed |
| US-20070021516-A1 | Halogen-free, flame-retardant polyurethane foams | LANXESS DEUTSCHLAND GMBH | 2007-01-25 | — | — | US | claimed |
| US-20260015372-A1 | Organophosphorous Compounds and Uses Thereof | JAL THERAPEUTICS LLC (US) | 2026-01-15 | — | — | US | disclosed |
| WO-2024020507-A2 | ORGANOPHOSPHOROUS COMPOUNDS AND USES THEREOF | JAL THERAPEUTICS, LLC (US) | 2024-01-25 | — | — | WO | disclosed |
| EP-3064540-B1 | FLAME RETARDANT CELLULOSE-ESTER PREPARATIONS | LANXESS DEUTSCHLAND GMBH (DE) | 2018-05-23 | — | — | EP | disclosed |
| US-9920081-B2 | Halogen-free poly(alkylene phosphates) | LANXESS DEUTSCHLAND GMBH (DE) | 2018-03-20 | — | — | US | disclosed |
| US-20160257704-A1 | FLAME-RETARDANT CELLULOSE ESTER PREPARATIONS | LANXESS DEUTSCHLAND GMBH (DE) | 2016-09-08 | — | — | US | disclosed |
| EP-3064540-A1 | FLAME RETARDANT CELLULOSE-ESTER PREPARATIONS | LANXESS Deutschland GmbH (DE) | 2016-09-07 | — | — | EP | disclosed |
| US-20140024734-A1 | HALOGEN-FREE POLY(ALKYLENE PHOSPHATES) | LANXESS DEUTSCHLAND GMBH (DE) | 2014-01-23 | — | — | US | disclosed |
| EP-2425945-A2 | Flame resistant wooden materials | LANXESS Deutschland GmbH (DE) | 2012-03-07 | — | — | EP | disclosed |
| EP-2425944-A1 | Flame resistant wooden materials | LANXESS Deutschland GmbH (DE) | 2012-03-07 | — | — | EP | disclosed |
| EP-1746129-B1 | Halogenfree, flameretardant polyurethane foams | LANXESS DEUTSCHLAND GMBH (DE) | 2009-01-14 | — | — | EP | disclosed |
| US-20070021516-A1 | Halogen-free, flame-retardant polyurethane foams | LANXESS DEUTSCHLAND GMBH | 2007-01-25 | — | — | US | disclosed |
| US-20070021516-A1 | Halogen-free, flame-retardant polyurethane foams | LANXESS DEUTSCHLAND GMBH | 2007-01-25 | — | — | US | disclosed |
| US-20070021516-A1 | Halogen-free, flame-retardant polyurethane foams | LANXESS DEUTSCHLAND GMBH | 2007-01-25 | — | — | US | disclosed |
| EP-1746129-A1 | Halogenfree, flameretardant polyurethane foams | Lanxess Deutschland GmbH (DE) | 2007-01-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160257704-A1 | FLAME-RETARDANT CELLULOSE ESTER PREPARATIONS | FIBP, PFKFB2, FABP4 | TSHR 1304/4885CYP3A4 2152/4885ALDH1A1 2028/4885 |
| US-20120058358-A1 | Flame-retardant timber materials | PFAS, CYP4F3, TARS2 | TSHR 226/4885CYP3A4 100/4885ALDH1A1 3321/4885 |
| US-20260015372-A1 | Organophosphorous Compounds and Uses Thereof | ACHE, BCHE, MUSK | TSHR 708/4885CYP3A4 1005/4885ALDH1A1 4365/4885 |
| US-20140024734-A1 | HALOGEN-FREE POLY(ALKYLENE PHOSPHATES) | PUF60, PCBP1, FFAR3 | TSHR 1431/4885CYP3A4 2735/4885ALDH1A1 4113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.